Kulich's Blood Clot Surgery Erases 2025-26, But Return Timeline Remains Opaque

Jiri Kulich confirmed Tuesday that he underwent a procedure in Minnesota two months prior to remove a blood clot that ended his 2025-26 season after just 12 games. The 22-year-old forward, selected 28th overall in the 2022 draft, played sparingly in early November before being shut down, accumulating three goals and five points in a truncated sample. Doctors have cleared him to resume skating, but the Sabres have offered no public timeline for his return to game action.

The medical nature of the shutdown matters for roster construction. A blood clot isn't a typical soft-tissue injury; it signals a systemic issue that requires ongoing monitoring. Even if Kulich skates without restriction during training camp, the Sabres will likely ease him into lineup minutes out of an abundance of caution. That conservatism—and the medical precedent it implies—shapes how Buffalo deploys him relative to preseason expectations and the salary-cap math that governed his contract when the organization drafted him.

From a forward-depth standpoint, Kulich's lost season redistributes minutes and linemate opportunity to internal options and potential free-agent targets. His absence forced the Sabres to lean harder on veterans and rookies who otherwise would have competed for third-line and depth reps against a prospect they drafted to eventually carry secondary offense. That structural shift doesn't reverse simply because he's cleared to play; integration into a functional line with rhythm already established elsewhere takes time.

For betting purposes, Kulich's game-total and assist props for 2026-27 carry significant execution risk in the early weeks. He has no in-season reps since November 2025, and medical clearance doesn't equal game fitness. Any books offering him at near-typical second-year forward expectations are not yet pricing the probability of a gradual ramp-up—limited shifts, fewer power-play touches until he finds his timing against live opposition. Early-season unders on his scoring total represent the more durable edge; the variance on when he achieves full lineup integration is simply too wide for the public-facing market to have modeled precisely at the 2026-27 open. Wait for him to play 8-10 games first; the real edge emerges once the Sabres show their true linemate and deployment strategy.